drugset / Trial / NCT00918515
Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043
RandomizedSingle-groupOpen-labelTreatment
Summary
This is a Phase I, single centre, open label study to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics of intravenous AZD3043 after single ascending doses in healthy male volunteers.
Timeline
- Start
- 2009-05
- Primary completion
- —
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD3043 | Small molecule | — | Intravenous |
Indications
No indication recorded.